Articles tagged with Cell Transplantation
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers at UC Davis Health developed a new treatment that simultaneously blocks IL-6 and TNF cytokines, providing superior protection against acute graft-versus-host-disease severity and mortality. The dual-cytokine blockade approach did not impair beneficial graft-versus-tumor effects.
A new gene and stem-cell therapy has been proven to be effective in treating Epidermolysis Bullosa (EB), a genetic skin disorder, without any side effects. The treatment, which involves transplanting genetically modified skin cells, has resulted in stable results after five years, with the patient now 13 years old.
A simple change in the way donor cells are processed can maximize a single cell's production of extracellular vesicles, which are small nanoparticles naturally secreted by cells. The finding offers new avenues for research around cellular therapies, where transplanted cells are used to help the body heal or work better.
Scientists at Kobe University have successfully generated testosterone-producing Leydig cells from human iPS cells, a significant step towards developing a regenerative medicine treatment for late-onset hypogonadism. The induced cells expressed genes specific to Leydig cells and produced functional testosterone.
A new study by USC researchers uses a genetic technology to analyze gene expression signatures of individual cancer cells from patients with leukemia. The findings show that cancer cells with distinct gene expression profiles tend to grow in different organs, while those with specific genes are more resistant to chemotherapy.
Researchers have developed a new method of stem cell transplantation that does not require chemotherapy or radiation. The approach uses immunotherapeutic drugs to eliminate cancer cells and prevent immune rejection. This technique has the potential to be curative for blood cancers and treat other diseases like sickle cell anemia.
Researchers report that 90% of patients who received gene therapy between 2009 and 2012 remain disease-free, with significant immune system differences observed among those treated. The therapy is most effective in younger children, but further work is needed to achieve high levels of gene correction in all patients.
A new pouch device has been developed to protect transplanted human liver cells from immune systems for up to six months, producing crucial biomolecules. This breakthrough offers a potential path toward treating human diseases without needing to suppress the patient's immune system.
Researchers have discovered the molecular mechanisms behind stem cell rolling in blood vessels, a complex process that slows down cells using long tethers. The findings offer new insights into improving stem cell transplantations and developing treatments for metastasizing cancers.
Researchers investigated antibody response to Pfizer-BioNTech vaccine in 117 allogeneic hematopoietic stem cell transplant recipients. The study aimed to assess vaccine safety and immune response in this population. Key findings were not reported in the article.
Researchers found that hematopoietic cell transplantation (HCT) normalizes the gut microbiota of patients with IBD associated with XIAP deficiency. The study revealed that HCT decreases gut inflammation and restores diversity in gut microbiota, improving symptoms and quality of life for affected individuals.
Scientists discovered beige fat cells mediate subcutaneous fat's brain protection and provide anti-inflammatory effects. Beige fat transplantation restored cognitive function in obese mice with dementia-like behavior.
Scientists at UCSF have shown that gene-edited cellular therapeutics can effectively treat major diseases such as peripheral artery disease, chronic obstructive pulmonary disease, and heart failure. The study used specially engineered induced pluripotent stem cells called HIP cells to evade the immune system.
A combination of ponatinib and blinatumomab achieves 100% complete response rate and 85% complete molecular remission in newly diagnosed patients, reducing the risk of treatment-related complications. The treatment is safe and well-tolerated, with no additional toxicity observed when used together.
Researchers have made new discoveries about fetal liver cells that could help make liver cell transplants more effective. Fetal liver cells can multiply and maintain function for long periods when used in transplants, but adult liver cells do not share this ability.
Researchers are developing new conditioning therapies with fewer side effects, targeting specific proteins on hematopoietic stem cells to make room for healthy ones. This could lead to more patients being able to safely undergo stem cell treatments, reducing complications and improving outcomes.
A new study finds that stem cell transplants after CAR T-cell therapy reduce relapse rates in childhood cancer patients by less than 10% two years later. The research suggests long-term benefits for young patients who receive the treatment, with most experiencing complete remission.
Non-circulating memory T cells play a crucial role in chronic transplant rejection by providing local protection against re-infection and causing prolonged immune responses. Targeting these cells could improve clinical transplant outcomes while preserving the immune system's ability to fight off infections.
A new analysis indicates that patients with kidney failure associated with sickle cell disease benefit from kidney transplantation to a similar extent as patients with kidney failure from other causes. Despite this, the sickle cell population is less likely to receive transplants.
A study found that intense immunosuppression followed by hematopoietic stem cell transplants can prevent disability associated with multiple sclerosis (MS) from getting worse in up to 71% of people with relapsing-remitting MS for up to 10 years. In some cases, disability improved over time.
A groundbreaking study by Liu et al successfully transplanted adult human eye stem cells into monkeys' eyes, restoring normal vision and supporting photoreceptor function. The retinal pigment epithelium-derived cells showed no serious side effects and integrated stably for at least three months.
Researchers found that removing the internal limiting membrane can help transplanted retinal cells integrate into the retina, improving vision loss caused by glaucoma and other diseases. The study aims to develop new ways to repair or replace lost optic neurons by growing new cells.
A mathematical model developed by researchers predicts that autologous gene-edited stem cell transplants could achieve viral control after antiretroviral therapy withdrawal. The conditions required for this include a sufficient dose of edited stem cells and allowing them to repopulate the blood before ART is stopped.
New research suggests that testing for tumor DNA in DLBCL patients' stem cells or blood can help predict relapse risk. Patients with positive results may benefit from alternative treatments like CAR T cell therapy and prompt interventions to prevent relapse.
A new clinical trial has found that donor stem cell transplantation nearly doubles the survival rate of older patients with higher-risk myelodysplastic syndrome (MDS), aged 50-75. The study suggests that transplant should be considered for all eligible patients, ideally referred early to increase chances of finding a suitable donor.
Researchers identified two cell signals that can guide stem cells to repair eye damage, increasing their survival and function after transplantation. The study's findings offer a promising approach to restoring eyesight by modifying stem cells with enhanced chemokine receptors.
A recent study by MedUni Vienna dermatologists has discovered that skin-resident and inactive T cells survive chemotherapy and radiotherapy intact and go on to cause inflammation after a stem cell transplant. In some cases, these tissue-resident T cells even prove beneficial to the recipient by assuming their role in immune defense.
Researchers describe a rare case of frosted branch angiitis, a unique presentation of florid retinal vasculitis, in a woman treated for leukemia-lymphoma with allogeneic human stem cell transplant. The condition led to immune activation and required corticosteroids to suppress inflammation.
Scientists have discovered that baking soda can reprogram T cells to resist cancer cells' immune-suppressive effects. The treatment has reversed the suppressive effects on T cells in 10 transplant recipients with relapsed AML.
Researchers at the University of Wisconsin-Madison have developed a stem cell treatment that repairs Parkinson's-damaged brain circuits in mice. The treatment involves coaxing human embryonic stem cells to differentiate into dopamine-producing neurons, which then integrate into the correct regions of the brain and restore motor functions.
Researchers developed an 'cell-less' therapy that accelerates recovery from heart attack in pigs by injecting tiny membrane-bound sacs containing proteins and DNA into the heart. This approach avoids safety concerns associated with whole-cell transplants, which often fail to engraft and can cause severe health issues.
Researchers at Keck School of Medicine of USC have received a five-year, $14.6 million grant to advance gene therapy for HIV control without daily medicines. The approach is inspired by three cases of HIV cure and aims to prepare patients for stem cell transplants with little toxicity.
Scientists at Joslin Diabetes Center have developed a novel cell-based therapy using 'HUMBLE' cells, genetically modified human white fat cells that mimic heat-generating brown fat cells. Transplanted into mice with type 2 diabetes, these cells improved insulin sensitivity and glucose clearance, reducing weight gain and related chronic...
Researchers studied iPS cell-derived heart muscle cells after transplantation to understand the phenomenon of irregular heartbeats. They found that the activity of working-type cells increases significantly, while nodal-like cells decrease in proportion, leading to a reduction in arrhythmia.
Testicular tissue transplantation combined with retinoic acid administration successfully produces healthy offspring in mice, offering a potential method for preserving/recovering male fertility. The researchers' findings suggest that this approach may be effective in humans without adverse effects on pregnant mothers.
Sylvester researchers have identified a potential protein target, STING, that may help mitigate graft versus host disease in stem cell transplants. In preclinical models, inhibiting the STING pathway reduced symptoms of GVHD.
A new study aims to enhance cord blood transplant success rates using a small molecule cell adhesion activator. The treatment has shown promise in preclinical studies and may provide a safer alternative to current methods.
A new cell therapy approach has been shown to reduce the need for immunosuppression in kidney transplant recipients, thereby minimizing the risk of side effects. The study found that regulatory cells were just as safe as standard treatment and did not result in higher rejection rates.
A new animal study demonstrates that transplanted human glial cells can repair damage and restore function in models of multiple sclerosis. The findings have significant therapeutic implications and represent a proof-of-concept for clinical trials.
A new method uses CAR-T therapy to eliminate leukemia stem cells and blood stem cells selectively, sparing mature blood cells and other tissues. The treatment is achieved through genetic modification of immune cells, which then target and destroy only the leukemic stem cells.
Using reprogrammed human skin cells, researchers successfully restored mobility and sensation in stroke-afflicted rats by transplanting them into their brains. The study showed that the transplanted cells formed connections correctly, repairing damaged nerve circuits.
Grafted neurons derived from human induced pluripotent stem cells functionally integrated into brain circuitry and restored motor function in stroke-injured rats. The study suggests that stem cell-derived neurons can replace dead cells to restore motor function.
Researchers at MIT have developed a way to encapsulate therapeutic cells in a flexible protective device that prevents immune rejection while allowing oxygen and nutrients to reach the cells. This technology could lead to long-term treatment of chronic diseases such as diabetes.
A newly discovered blood marker has been linked to a patient's subsequent risk of kidney transplant failure in a study of 284 kidney transplant recipients. The composition of immune cells called CD8+ memory T cells 1 year after kidney transplantation was found to be a critical factor in predicting organ rejection.
A study of a second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy. The patient had a healthy CD4 cell count, suggesting they have recovered well from the transplant.
A phase 2 randomized trial study found that patients who received the Triplex vaccine had 50% fewer CMV complications and developed immunity against the virus. The vaccine showed promise as a potential therapy for transplant recipients with weakened immune systems.
Researchers found that iPSC-derived thymic epithelium cells can regulate immune response to skin grafts, extending their survival. The introduction of Foxn1 gene helps efficient differentiation of such cells.
A new study in 50 patients found that persistent mixed chimerism can reduce the reliance on immunosuppressive drugs after a kidney transplant. The treatment achieved immune tolerance and reduced rejection episodes, allowing some patients to survive with their donated kidneys for over eight years.
A pilot study of 25 donor-recipient pairs reveals young stem cell donors have previously undetected and potentially disease-causing mutations in their blood stem cells. These mutations, linked to post-transplant complications, are more prevalent in young donors than thought.
A recent study found that oral infections are not linked to increased risk of death or serious infection after stem cell transplantation. The researchers suggest that conservative dental treatment may be sufficient for patients with asymptomatic dental infections, and radical treatment is only necessary in specific cases.
A new analysis reveals that donor stem cell transplantation following PD-1 treatment is generally safe and produces good outcomes for patients with Hodgkin lymphoma. Post-transplant treatment with cyclophosphamide may also lead to improved results, reducing rates of acute GVHD and relapse.
A study by Dana-Farber researchers suggests that adding venetoclax to a reduced-intensity drug regimen prior to stem cell transplant can increase the chances of transplant success. The treatment has been found to be safe and does not impair donor cells' ability to engraft in recipients.
Researchers identified genetic mutations that predict patient outcomes after a stem cell transplant for acute myeloid leukemia (AML) in patients over age 60. Patients with specific gene mutations were classified into low, high, or intermediate-risk groups, enabling personalized treatment approaches.
Researchers have found that abatacept significantly reduces severe acute GvHD in high-risk patients, with a one-year survival rate of 85%. The drug suppresses effector T cells, which can also trigger infections or relapse in cancer patients.
Researchers have successfully transplanted human neurons into a mouse brain, allowing them to study human neural circuit formation and potential diseases. The transplanted cells followed a months-long period of maturation typical for human neurons and were able to function in the mouse neural circuits.
Researchers at the University of California, Irvine developed a cell therapy that transplants inhibitory neurons to improve memory precision after traumatic brain injury. The treatment prevented seizures in mice with traumatic brain injuries, showing promising results for potential human treatment.
By adding amniotic epithelial cells to pancreatic islet clusters, researchers created more robust
Researchers have made a groundbreaking discovery in blood stem cell transplantation using the UM171 molecule, which significantly reduces graft rejection and mortality rates. The treatment has shown impressive results in clinical trials with low mortality rates and no chronic autoimmune disease development.
Engineered cell sheets have been designed to effectively treat open skin areas after surgeries, addressing a major challenge in post-operative care. The method involves scanning the surgical site, designing and printing a 3D mold, coating it with gold, seeding cells, and growing a custom-made cell sheet that can be transplanted into mice.
In a breakthrough, Johns Hopkins Medicine researchers successfully transplanted protective brain cells into mice without the need for lifelong anti-rejection drugs. The innovative approach exploits the immune system's natural tendencies to accept transplanted cells as 'self', allowing them to thrive and protect brain tissue long-term.